Humira levels linked to biologic Crohn’s remission

Patients with optimized Humira drug levels were more likely to achieve biologic remission, according to research published in Inflammatory Bowel Diseases.
“It is increasingly recognized that clinical symptom activity indices correlate poorly with the degree of underlying intestinal inflammation,” Nikolas Plevris, MRCP, of the Edinburgh IBD Unit at Western General Hospital in Edinburgh, Scotland, and colleagues wrote. “In the era of treating beyond symptoms, data are emerging that even higher serum drug levels are required to achieve objective end points like mucosal healing.”

Source link

Related posts

CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis


Information for Authors and Readers


Colorectal Cancer—Recent Advances and Future Challenges


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy